Apomorphine in Parkinson's Disease Patients With Visual Hallucinations

NCT02702076 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Hallucinations, Visual

Interventions

DRUG: Apomorphine
DRUG: Placebo

Sponsor

University Medical Center Groningen